Alternatives to Enteral Access Technologies

Develops a brain-computer interface for treating epilepsy.

Develops intravascular lithotripsy technology for treating calcified cardiovascular lesions.

Medical device company developing and commercializing clot removal devices for venous diseases.

AI-powered EEG device for rapid seizure detection in critical care.

Develops an AI-driven surgical navigation platform using 3D ultrasound for enhanced cancer treatment.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

Develops a minimally invasive implantable device for treating type 2 diabetes and obesity.

Global healthcare and homecare partner providing medical devices, products, and innovative solutions.

Develops a point-of-care diagnostic platform for rapid and accurate disease detection.

Developing minimally invasive water vapor ablation therapy to treat prostate, kidney, and bladder cancer.

CairnSurgical is developing the Breast Cancer Locator™ System to improve breast-conserving surgery by enhancing tumor localization and tissue inspection.

Medical technology company developing anesthesia-free kidney stone treatment.

Develops innovative surgical technology to make bone surgery safer and more precise by protecting soft tissues.

Pioneering bio-engineered skin grafts for severe burns and chronic wounds.

Femasys is a biomedical company developing minimally invasive, in-office technologies for women's reproductive health, including fertility and permanent birth control solutions.

Develops advanced wound care solutions utilizing proprietary bio-active materials.

Organox develops and commercializes medical devices for organ preservation and assessment, aiming to improve outcomes for transplant patients.

Medasense quantifies pain response using breakthrough NOL® AI technology to optimize patient care and avoid overmedication.

Eyebot is a startup developing AI-powered robotic solutions for automated eye care and vision testing.